# 65219-572-10 · Bumetanide Injection · Fresenius Kabi USA, LLC — FDA drug shortage duration tracker

For 65219-572-10 · Bumetanide Injection · Fresenius Kabi USA, LLC, package ndc is 65219-572-10; generic name is Bumetanide Injection; manufacturer is Fresenius Kabi USA, LLC; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 65219-572-10 _(verified: appears in the quote below)_
- **Generic name:** Bumetanide Injection _(verified: appears in the quote below)_
- **Manufacturer:** Fresenius Kabi USA, LLC _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **FDA note:** Check wholesalers for inventory _(verified: appears in the quote below)_
- **Initial posting date:** 01/31/2018 _(verified: appears in the quote below)_
- **Last update date:** 08/25/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3135 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Cardiovascular _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "01/31/2018", "package_ndc": "65219-572-10", "generic_name": "Bumetanide Injection", "contact_info": "888-386-1300", "availability": "Available", "related_info": "Check wholesalers for inventory"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/25/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)", "company_name": "Fresenius Kabi USA, LLC", "status": "Current"

### Status

> "update_date": "08/25/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)", "company_name": "Fresenius Kabi USA, LLC", "status": "Current"

### Last update date

> "update_date": "08/25/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)", "company_name": "Fresenius Kabi USA, LLC", "status": "Current"

### Dosage form

> "update_date": "08/25/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)", "company_name": "Fresenius Kabi USA, LLC", "status": "Current"

### Therapeutic category

> "update_date": "08/25/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)", "company_name": "Fresenius Kabi USA, LLC", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).